SCHEMBL5521055

SCHEMBL5521055

CC(=O)c1cccc(C(C)=NNC(N)=S)c1

nearest known ligand 0.84

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.74
CTSL P07711 1/20 0.68
ATM Q13315 1/20 0.66
METTL3 Q86U44 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5521050 1.00 ALDH1A1 (0.74) ALDH1A1CTSLATMMETTL3
SCHEMBL5522779 0.83 CTSL (0.70) ALDH1A1CTSLATMMETTL3
SCHEMBL5519818 0.83 CTSL (0.70) ALDH1A1CTSLATMMETTL3
SCHEMBL13954747 0.83 CTSL (0.70) ALDH1A1CTSLATMMETTL3
SCHEMBL5522782 0.83 CTSL (0.70) ALDH1A1CTSLATMMETTL3
SCHEMBL940737 0.83 CTSL (0.70) ALDH1A1CTSLATMMETTL3
SCHEMBL941204 0.83 CTSL (0.70) ALDH1A1CTSLATMMETTL3
SCHEMBL17527524 0.83 CTSL (0.70) ALDH1A1CTSLATMMETTL3
Phenyl(Methyl)Thiosemicarbazone SCHEMBL27879446 0.82 METTL3 (0.90) ALDH1A1ATMMETTL3
SCHEMBL8443303 0.81 CTSL (0.68) CTSLATMMETTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197495-A1 ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197495-A1 ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE CYP51A1, TUBA3C, PIGO ALDH1A1 860/4885CTSL 5/4885ATM 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.